Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04540705
Title A Study to Evaluate the Triplet Combination of Bempegaldesleukin (Bempeg/NKTR-214) Plus Nivolumab and Axitinib and the Doublet Combination of Nivolumab and Axitinib in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread (PIVOT IO 011)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

renal cell carcinoma

Therapies

Axitinib + Nivolumab + NKTR-214

Axitinib + Nivolumab

Age Groups: adult | senior
Covered Countries USA | FRA | DEU | CAN

Facility Status City State Zip Country Details
Local Institution - 0005 Springdale Arkansas 72762 United States Details
Local Institution Louisville Kentucky 40202 United States Details
Local Institution - 0001 Saint Louis Missouri 63110 United States Details
Local Institution - 0009 New York New York 10065 United States Details
Local Institution Portland Oregon 97213 United States Details
Local Institution Nashville Tennessee 37232 United States Details
Local Institution - 0014 Houston Texas 77030-3721 United States Details
Local Institution - 0007 Seattle Washington 98109 United States Details
Local Institution Mar del Plata Buenos Aires B7600 Argentina Details
Local Institution Rio Cuarto Cordoba 5800 Argentina Details
Local Institution Buenos Aires Distrito Federal C1419AHN Argentina Details
Local Institution San Juan 5400 Argentina Details
Local Institution Belo Horizonte Minas Gerais 30130-090 Brazil Details
Local Institution Curitiba Parana 80730-150 Brazil Details
Local Institution Porto Alegre RIO Grande DO SUL 91350-200 Brazil Details
Local Institution Santa Cruz do Sul RIO Grande DO SUL 96810-110 Brazil Details
Local Institution Barretos SAO Paulo 14784-400 Brazil Details
Local Institution Edmonton Alberta T6G 1Z2 Canada Details
Local Institution - 0015 Vancouver British Columbia V5Z 4E6 Canada Details
Local Institution - 0008 Toronto Ontario M5G 1Z5 Canada Details
Local Institution Bordeaux 33075 France Details
Local Institution Brest 29200 France Details
Local Institution Lyon 69008 France Details
Local Institution - 0079 Marseille 13273 France Details
Local Institution Nice cedex 2 06189 France Details
Local Institution Strasbourg 67200 France Details
Local Institution - 0045 Hannover 30625 Germany Details
Local Institution - 0044 Munich 81675 Germany Details
Local Institution - 0046 Würzburg 97080 Germany Details
Local Institution Mexico City Distrito Federal 14080 Mexico Details
Local Institution Zapopan Jalisco 45070 Mexico Details
Local Institution Monterrey Nuevo LEON 64460 Mexico Details
Local Institution Queretaro 76000 Mexico Details
Local Institution Moscow 115478 Russian Federation Details
Local Institution Moscow 121205 Russian Federation Details
Local Institution Moscow 121359 Russian Federation Details
Local Institution Novosibirsk 630099 Russian Federation Details
Local Institution Omsk 644013 Russian Federation Details
Local Institution Saint-Petersburg 197758 Russian Federation Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field